Health Policy and Technology最新文献

{"title":"Cost effectiveness of esophageal varices screening strategies of cirrhotic patients with portal hypertension","authors":"Claire Cavalin ,&nbsp;Solène Schirr-Bonnans ,&nbsp;Astrid Darsonval ,&nbsp;Valéry-Pierre Riche ,&nbsp;Solène Brunet-Houdard ,&nbsp;Fanny Monmousseau ,&nbsp;Emmanuel Nowak ,&nbsp;Geneviève Perrocheau ,&nbsp;Nathalie Andreu ,&nbsp;Sophie Tollec ,&nbsp;Myriam Le Goff Pronost ,&nbsp;Emma Bajeux ,&nbsp;Sylvie Sacher-Huvelin","doi":"10.1016/j.hlpt.2024.100925","DOIUrl":"10.1016/j.hlpt.2024.100925","url":null,"abstract":"<div><h3>Objectives</h3><div>In France, screening for esophageal varices (EVs) in cirrhotic patients with portal hypertension (PH) is performed by esophagogastroduodenoscopy (EGD). Though proven effective, EGD screening may be unpleasant for some patients. Our study sought to compare the cost-effectiveness of PillCam (Medtronic, Minneapolis, USA) esophageal capsule endoscopy (ECE), a less invasive test, versus EGD, for EV screening, from the perspective of the French national health system (NHS). In secondary objectives we compared the cost-effectiveness of ECE versus no screening for patients not compliant with EGD screening, and the cost-effectiveness of a screening strategy (ECE or EGD) versus no screening strategy at all.</div></div><div><h3>Methods</h3><div>We constructed a Markov model with data from the literature, applying it to two simulated cohorts of adult patients with cirrhosis and PH not previously screened for EVs. These patients were divided into EGD and ECE screening arms and tracked over a virtual 10-year period. Cost-effectiveness was defined as cost (in euros) per quality-adjusted life year (QALY).</div></div><div><h3>Results</h3><div>In the base-case analysis, ECE is more expensive than EGD (€3,606 vs. €3,030) and less effective by 0.0098 QALY (5.2099 vs. 5.2197 QALYs). Probabilistic sensitivity analysis shows that ECE has only a 2.1 % probability of being cost-effective at willingness-to-pay (WTP) of €30,000/QALY.</div></div><div><h3>Conclusions</h3><div>Although patient compliance is apparently higher with ECE, it is not cost-effective at a WTP of €30,000/QALY and should not be considered in all patients with PH. Its cost-effectiveness should be reevaluated in the event of patient refusal of EGD follow-up.</div></div><div><h3>Public Interest Summary</h3><div>Esophagogastroduodenoscopy (EGD) is gold standard to screen cirrhotic patients with portal hypertension for esophageal varices, but its unpleasantness lowers compliance. We evaluated the cost-effectiveness of a more acceptable alternative for patients: the esophageal capsule endoscopy (ECE).</div><div>Our results show that screening by ECE is more expensive and less effective than by EGD from the perspective of the French national health system. It cannot be used as an alternative for all patients suffering from PH in France. Further investigations could be conducted to assess the effectiveness of ECE for the sub population of patients with PH who are totally refractory to EGD and may suffer from inadequate follow-up due to lack of screening.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 5","pages":"Article 100925"},"PeriodicalIF":3.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142587307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The impact of emerging technologies on healthcare needs of older people","authors":"Tal Soffer ,&nbsp;Yoel Raban ,&nbsp;Sigalit Warshawski ,&nbsp;Sivia Barnoy","doi":"10.1016/j.hlpt.2024.100935","DOIUrl":"10.1016/j.hlpt.2024.100935","url":null,"abstract":"<div><h3>Background</h3><div>The global elderly population is rapidly increasing resulting in a higher burden on healthcare systems. Emerging technologies may contribute to counteracting the shortage of healthcare workers and to assist the elderly in both healthcare settings and the community.</div></div><div><h3>Objective</h3><div>The study aimed to identify emerging technologies that may have a significant impact on the healthcare and social needs of the elderly, to assess their time to market, and to recommend policy measures intended to overcome entry barriers.</div></div><div><h3>Methods</h3><div>A foresight study was conducted, including horizon scanning, interviews, and a survey of 76 participants who were experts from the fields of health and technology in Europe and Israel.</div></div><div><h3>Results</h3><div>Thirteen emerging technologies were identified and five main areas of needs for the elderly were recognized: mobility, cognition, self-care, social life, and access to healthcare. All the emerging technologies were shown to have a high impact on healthcare needs for the elderly. The most influencing technologies were wearables, artificial intelligence apps and fall prevention devices. The most influential area of need was self-care, while the lowest area was social life. The forecast was that most technologies will reach the market as early as 2024 and will continue to evolve and impact healthcare. The significant barriers were forecasted to be high cost, lack of ease of use, and training.</div></div><div><h3>Conclusions</h3><div>The important policy measures are to increase usability and the availability of solutions, public funding, and training.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 5","pages":"Article 100935"},"PeriodicalIF":3.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142572134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinicians’ perspective of the opioid analgesic stewardship in acute pain clinical care standard","authors":"Chelsea Dutkiewicz ,&nbsp;Shania Liu ,&nbsp;Asad Patanwala ,&nbsp;Andrew J McLachlan ,&nbsp;Jennifer Stevens ,&nbsp;Kok Eng Khor ,&nbsp;Bernadette Bugeja ,&nbsp;David Begley ,&nbsp;Ian Fong ,&nbsp;Katelyn Jauregui ,&nbsp;Jonathan Penm","doi":"10.1016/j.hlpt.2024.100936","DOIUrl":"10.1016/j.hlpt.2024.100936","url":null,"abstract":"<div><h3>Objectives</h3><div>Opioid analgesics are high-risk medicines, widely used in hospitals to manage pain. To improve the use of opioids in Australia, The Australian Commission on Safety and Quality in Health Care released the first national Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard (Opioid Stewardship Standard). The objective of this study was to explore clinicians’ perspectives of the implementation of the Opioid Stewardship Standard to understand factors that may impact this process.</div></div><div><h3>Methods</h3><div>Qualitative one-on-one interviews were conducted with clinicians, including doctors, pharmacists, nurses, and patient safety officers. The interview guide was developed based on the Consolidated Framework of Implementation Research. Interview transcriptions were thematically analyzed using an inductive approach to identify common themes.</div></div><div><h3>Results</h3><div>In total, 32 clinicians were interviewed, including 10 doctors, 10 pharmacists, and 12 nurses from 26 sites across Australia. Themes identified included: (i) Organizational priorities, (ii) organizational capacity for implementation, (iii) changing prescribing practices, and (iv) the Opioid Stewardship Standard.</div></div><div><h3>Conclusions</h3><div>Clinicians’ perceptions were categorized into four themes regarding the implementation of the Opioid Stewardship Standard. Key findings from this study included the importance of local data to increase organizational prioritization, availability of resources and staffing to increase organizational capacity for implementation to implement the Opioid Stewardship Standard. Future studies should evaluate the impact of such strategies on implementation.</div></div><div><h3>Lay summary</h3><div>Health professionals need more support from the health system to deliver health care that aligns with policies such as the Opioid Stewardship Standard. Organisations within the health system should consider providing support such as staffing to meet these needs.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 5","pages":"Article 100936"},"PeriodicalIF":3.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142663732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An empirical study looking at the potential impact of increasing cost-effectiveness threshold on reimbursement decisions in Thailand","authors":"Wanrudee Isaranuwatchai ,&nbsp;Yi Wang ,&nbsp;Budsadee Soboon ,&nbsp;Kriang Tungsanga ,&nbsp;Ryota Nakamura ,&nbsp;Hwee-Lin Wee ,&nbsp;Siobhan Botwright ,&nbsp;Wannisa Theantawee ,&nbsp;Jutatip Laoharuangchaiyot ,&nbsp;Thanakrit Mongkolchaipak ,&nbsp;Thanisa Thathong ,&nbsp;Pritaporn Kingkaew ,&nbsp;Yot Teerawattananon","doi":"10.1016/j.hlpt.2024.100927","DOIUrl":"10.1016/j.hlpt.2024.100927","url":null,"abstract":"<div><h3>Background</h3><div>There has been lots of debate regarding an appropriate value of cost-effectiveness threshold (CET). To our knowledge, Thailand is the only country which has explicit CET and has increased the CET. Therefore, Thailand is in a unique position to help answer the question of what happened when CET was increased. The study objectives were to explore the impact of increasing CET on the submitted medicine price by industry and the decision to be included in the National List of Essential Medicine in Thailand.</div></div><div><h3>Methods</h3><div>Retrospective secondary data analyses were conducted using data from economic evaluation reports being reviewed by the National Drug Subcommittee. In total, 55 reports were included in the analysis, which represented 295 observations as each report could have more than one medicine for different indication and/or target population. The intervention of interest was the change in CET policy from 100,000 THB/QALY in 2008 to 120,000 THB/QALY in 2010 to 160,000 THB/QALY in 2013.</div></div><div><h3>Results</h3><div>There is no evidence suggesting the increase in CET affected the submitted medicine prices (price change=19%, p-value=0.457) or increased the likelihood of a positive reimbursement decision (OR=1.596, p-value=0.532). There were other factors which may influence medicine prices and reimbursement decision.</div></div><div><h3>Conclusions</h3><div>The change in the CET did not significantly affect health resource allocation. The findings do not support whether the current CET value in Thailand should be increased. Future research should continue to monitor the submission and re-analyse the current work as more data become available using both quantitative and qualitative approaches.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 6","pages":"Article 100927"},"PeriodicalIF":3.4,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142651678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reflecting on relaxing zero-COVID and moving forward with positivity: A population-based quantitative and qualitative study","authors":"Ruihua Li ,&nbsp;Chuanning Huang ,&nbsp;Beier Guan ,&nbsp;Jiang Du ,&nbsp;Min Zhao ,&nbsp;Shuyan Liu","doi":"10.1016/j.hlpt.2024.100929","DOIUrl":"10.1016/j.hlpt.2024.100929","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objectives&lt;/h3&gt;&lt;div&gt;The event that China lifted its zero-COVID policy in December 2022 promoted this study to investigate people's responses in terms of health, mood, life satisfaction, and policy satisfaction following the policy relaxation.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;We conducted a cross-sectional online survey one month after relaxing zero-COVID policy among Chinese general population using qualitative and quantitative approaches. Participants rated their health, mood, life satisfaction, and policy satisfaction on a horizontal visual analogue scale ranging from 1 to 100. In addition, we included open-ended questions to gain deeper insights into their responses.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Out of 4456 participants, approximately 70 % reported satisfaction following the policy change. Those with recent COVID-19 infection (N = 3308) rated lower scores in health, mood, life satisfaction, and policy satisfaction than those without recent infection. A multiple linear regression model revealed that the absence of recent COVID-19 infection, higher life satisfaction, and greater policy satisfaction were associated with better mood. Interestingly, participants who experienced increases in life and policy satisfaction also had better moods. Qualitative analysis revealed an improved mood of participants, reflecting a desire to return to normal life despite a preference for a gradual and well-prepared transition policy.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;This study highlighted positive changes following the relaxation of zero-COVID policy. Strategies aiming at post-COVID-19 recovery should prioritize individuals who have contracted the virus while promoting life and policy satisfaction amongst the general population.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Public Interest Summary&lt;/h3&gt;&lt;div&gt;China's decision to lift its dynamic zero-COVID policy on December 7, 2022, marked a significant shift in COVID-19 control measures, ushering in immediate stressors and challenges. Our study, employing both quantitative and qualitative methods, sought to understand how the general population in China responded to this transition. We found that participants reported above-average levels of self-assessment health, mood, life satisfaction, and policy satisfaction following the relaxation of the zero-COVID policy. Notably, those with recent COVID-19 infection reported lower satisfaction levels than those without recent infection. Moreover, the absence of recent COVID-19 infection, higher life satisfaction, and greater policy satisfaction were associated with better mood outcomes. In addition, we observed a positive synergistic effect between life satisfaction and policy satisfaction on mood. Despite a preference for a gradual and well-prepared transition policy, participants showed improved mood, reflecting an inclination towards a return to normalcy. Our study captured this pivotal moment of policy change, revealing positive changes to move forward amid complex","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 6","pages":"Article 100929"},"PeriodicalIF":3.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142651573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perspectives on access to imaging digital health records in oncology: A mixed methods systematic review","authors":"Ana S.F. Ribeiro ,&nbsp;Olga Husson ,&nbsp;Milou Reuvers ,&nbsp;Wim J.G. Oyen ,&nbsp;Christina Messiou ,&nbsp;Winette T.A. van der Graaf","doi":"10.1016/j.hlpt.2024.100915","DOIUrl":"10.1016/j.hlpt.2024.100915","url":null,"abstract":"<div><h3>Background</h3><div>Digital Health Records (DHR) have become essential for managing patient data, including radiology and nuclear medicine reports. The wider adoption of DHR globally presents an opportunity to improve patient engagement and empowerment through effective access and sharing of imaging investigations. This review aims to synthesize literature on views, experiences, expectations, and preferences of oncology patients and healthcare professionals (HCP) when accessing imaging via DHR.</div></div><div><h3>Materials and Methods</h3><div>This review was conducted using recommended Cochrane Handbook databases (registration: CRD42021213808), focusing on English articles published from 2000 onwards. Three experienced reviewers critically appraised selected articles, thematic analysis and narrative synthesis were used to extract data.</div></div><div><h3>Results</h3><div>493 unique articles were identified, with 451 excluded, resulting in 42 articles assessed for eligibility. Nine studies were included, eight from the USA, one from Canada, published between 2010 and 2020. Findings suggest patient portals can positively impact patient and HCP engagement, and patients desire access to their imaging reports. Factors such as timing of access, adequate consultation time, resources for HCP to discuss findings, and format of information are critical considerations that influence both patient and HCP perceptions and preferences.</div></div><div><h3>Conclusion</h3><div>Oncology patients want timely and understandable access to their imaging records. To ensure this, it is crucial to explore the appropriate timing, format, and methods to discuss these findings with patients. By involving all stakeholders in the planning process, we can develop DHR systems that provide personalised support for patients to manage their complex imaging results.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 5","pages":"Article 100915"},"PeriodicalIF":3.4,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142531825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Introduction of novel complex integrated care models supported by digital health interventions in European primary settings: a scoping review","authors":"E. Mezzalira ,&nbsp;F. Canzan ,&nbsp;G. Marini ,&nbsp;J. Longhini ,&nbsp;C Leardini ,&nbsp;L. Saiani ,&nbsp;E. Ambrosi","doi":"10.1016/j.hlpt.2024.100896","DOIUrl":"10.1016/j.hlpt.2024.100896","url":null,"abstract":"<div><h3>Introduction</h3><p>There remains the need to develop comprehensive organisational care models supported by digital health interventions (DHIs) to manage chronic conditions in primary healthcare.</p></div><div><h3>Objective</h3><p>this review aimed to identify and map methods, interventions and outcomes investigated regarding the introduction of novel complex integrated care models supported by DHIs in the European primary care setting, as well as the level of integration achieved.</p></div><div><h3>Methods</h3><p>a scoping review to identify literature from 2013 to 2023 in the European context was conducted across PubMed, Scopus and Web of Science. DHIs description, care models and outcomes were reported using the PRISMA- ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines.</p></div><div><h3>Results</h3><p>A total of 53 studies was included. The models introduced, along with a DHI, at least one innovation in their structure or in the modality of care delivery: either a new figure (44%), interprofessional collaboration (37%), new functions like person-centred care (59%) or population stratification (11%). As regarding the DHIs, 56% implemented monitoring/management platforms and apps for chronic conditions. The most frequent combination of care model-DHI was the introduction of an app/platform, supported by phone calls/texts and electronic health records, paired with the introduction of a new healthcare professional/person centred care/ multidisciplinary team. All the studies reaching statistically significant outcomes introduced, along with one or more DHIs, either a new figure or a multidisciplinary team as part of the organizational change to support the technology.</p></div><div><h3>Conclusions</h3><p>novel complex integrated care models are focusing on introducing multidisciplinary perspectives and personalization of care, in line with the complex needs of chronic patients. The predominant development of monitoring/management platforms for patients is a further confirmation of this trend. Future research efforts should focus on the investigation of the effectiveness of current complex integrated care models integrating DHIs.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 4","pages":"Article 100896"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883724000595/pdfft?md5=6bf4b87855b7fec46abc3295455a593f&pid=1-s2.0-S2211883724000595-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142094787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identifying the risk factors of patient safety in internet hospitals: A mixed methods study","authors":"Sha Liu ,&nbsp;Yinhuan Hu ,&nbsp;Xiaoyue Wu ,&nbsp;Gang Li ,&nbsp;Liuming Wang ,&nbsp;Yeyan Zhang ,&nbsp;Jinghan Zhou","doi":"10.1016/j.hlpt.2024.100897","DOIUrl":"10.1016/j.hlpt.2024.100897","url":null,"abstract":"<div><h3>Objective</h3><p>The purpose of this study was to identify key risk factors and their interrelationships for patient safety in internet hospitals from a system perspective, using mixed methods of qualitative and quantitative analysis.</p></div><div><h3>Methods</h3><p>This study constructed a comprehensive indicator system of patient safety risk factors in internet hospitals by qualitative analysis using the Patient Safety Systems (SEIPS) model as a framework. Risk factors were initially identified through a literature review and subsequently refined using a Delphi survey involving 24 experts related to internet hospitals in China. The identified indicators were quantitatively analyzed to determine key risk factors and their influencing mechanism using the Decision Making Trial and Evaluation Laboratory (DEMATEL) and Interpretive Structural Modeling (ISM) methods.</p></div><div><h3>Results</h3><p>The qualitative analysis established a patient safety risk factor indicator system for internet hospitals, comprising 23 elements across six dimensions. Quantitative analysis employing the DEMATEL-ISM approach revealed that risk management has the highest centrality. Among cause factors, task complexity exerts the most significant impact on other factors, while network information security exhibits the highest absolute value among result factors. Risk factors are categorized into three levels: surface, deep, and root factors, with task complexity, legal and regulatory, and guidance policy being the root factors at the foundation of the system.</p></div><div><h3>Conclusions</h3><p>Our study offered a systemic perspective on analyzing risk factors for patient safety in internet hospitals. Policymakers and managers of internet hospitals should take advantage of the interrelationships among these factors to mitigate patient safety risks by effectively controlling key factors.</p></div><div><h3>Public Interest Summary</h3><p>In the rapidly evolving landscape of internet hospitals, ensuring patient safety is paramount. This study aimed to comprehensively identify and understand key risk factors influencing patient safety within these digital healthcare platforms. Using mixed methods of qualitative and quantitative analysis, the study examined the intricate interplay of factors affecting patient safety. Our methodology involved constructing a risk factors indicator system based on the Patient Safety Systems (SEIPS) model. By employing the integrated Decision-Making Trial and Evaluation Laboratory along with the Interpretive Structural Modeling method, we unveiled the core risk factors and their intricate relationships. Recognizing the interconnectivity of these factors allows us to develop effective risk mitigation strategies that enhance patient safety in internet hospitals. This study encourages stakeholders to leverage the dynamic relationships among these factors to ensure safer online healthcare experiences for patients.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 4","pages":"Article 100897"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142094786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A qualitative study on pharmacists’ perceptions about service innovation","authors":"Artemisa R. Dores ,&nbsp;Miguel Peixoto ,&nbsp;Irene P. Carvalho ,&nbsp;Maria Castro ,&nbsp;António Marques","doi":"10.1016/j.hlpt.2024.100898","DOIUrl":"10.1016/j.hlpt.2024.100898","url":null,"abstract":"<div><h3>Background</h3><p>Expanded services provided at pharmacies show numerous improvements in health outcomes. However, attempts at implementing new services in pharmacies are met with several barriers, among which is the failure to update the pharmacist's role.</p></div><div><h3>Objective</h3><p>This study aimed to explore pharmacists’ perceptions about the role of pharmacies and the effects of, and barriers to, service expansion.</p></div><div><h3>Methods</h3><p>Four focus groups were conducted with pharmacists from across Portugal, and an inductive content analysis was applied to the transcribed sessions.</p></div><div><h3>Results</h3><p>The content analysis results were organized into three main categories: the Role of Pharmacy, Potentialities of Service Innovation, and Service Innovation. The results emphasize the importance of enhancing pharmacists’ training, establishing supportive legal frameworks, prioritizing funding for technological advancements, promoting interprofessional collaboration, and embracing innovative practices to advance healthcare innovation and improve patient outcomes.</p></div><div><h3>Conclusions</h3><p>The identification of several tasks indicates that, in pharmacists’ perspectives, the Role of Pharmacy ranges from dispensing medication to aiding/monitoring patients at various stages of their health conditions. Expanded services were associated with several emergent Potentialities of Service Innovation, namely, enhancement of health outcomes and help to main healthcare facilities dealing with an increased number of patients. For Service Innovation, several factors emerged that need consideration, such as the conditions and the difficulties found associated with new service implementation. These pertain to pharmacists, legislation, and resources.</p></div><div><h3>Public Interest Summary</h3><p>Background: Expanded services provided at pharmacies show numerous improvements in health outcomes. However, several barriers should be addressed. Objective: This study sought to explore pharmacists’ perceptions about the role of pharmacies and the effects of, and barriers to, service expansion. Methods: A content analysis was applied to four focus groups conducted with pharmacists from across Portugal. Results: The three main emerging categories were: The Role of Pharmacy, divided into assessment, referrals, therapy monitoring, educating/informing, prescribing, and registering; Potentialities of Service Innovation, divided into proximity, improvement, and competitiveness; Service Innovation, divided into conditions for implementation, implementation difficulties, activation of the new services, and adherence-promoting factors. Conclusion: The pharmacy role goes beyond dispensing medication. Tied to this expanded role, pharmacists identified several advantages that the services could provide and several barriers to Service Innovation. Factors that promote adherence need more extensive study.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 4","pages":"Article 100898"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883724000613/pdfft?md5=11d49cca380593e77280af303b498829&pid=1-s2.0-S2211883724000613-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142172923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Digital approaches in myositis","authors":"Shinji Izuka ,&nbsp;Parikshit Sen ,&nbsp;Toshihiko Komai ,&nbsp;Keishi Fujio ,&nbsp;Johannes Knitza ,&nbsp;Latika Gupta","doi":"10.1016/j.hlpt.2024.100906","DOIUrl":"10.1016/j.hlpt.2024.100906","url":null,"abstract":"","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 4","pages":"Article 100906"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}